Concerns Regarding NSCLC Immunoradiotherapy Study Interpretability

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

1 Downloads (Pure)

Access to Document

Full text
Final published version, 68.5 KB
Licence: Taverne
Embargo ends: 06/02/2027 00:00 CET
Request copy

@article{31e1ec375cd04a62a5b900f4ef55a25a,

title = "Concerns Regarding NSCLC Immunoradiotherapy Study Interpretability",

author = "Mandy Jongbloed and \{De Ruysscher\}, \{Dirk K. M.\} and Hendriks, \{Lizza E. L.\}",

year = "2026",

month = aug,

day = "1",

doi = "10.1001/jamaoncol.2026.2921",

language = "English",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

}